Patterns of polyp histology: predictors of peril in the mucosa.
adenoma
carcinogenesis
colorectal mucosa
polyp
serrated polyp
Journal
ANZ journal of surgery
ISSN: 1445-2197
Titre abrégé: ANZ J Surg
Pays: Australia
ID NLM: 101086634
Informations de publication
Date de publication:
05 2020
05 2020
Historique:
received:
20
07
2019
revised:
27
11
2019
accepted:
08
12
2019
pubmed:
14
2
2020
medline:
15
5
2021
entrez:
14
2
2020
Statut:
ppublish
Résumé
Precursor colonic polyps of varied subtypes correlate with the known neoplastic pathways. When patients present with synchronous pre-malignant polyps of multiple histologies, multiple genetic mechanisms are likely to be active, potentially resulting in a more unstable, tumourigenic mucosa. We hypothesized that patients with a combination of sessile serrated adenomas/polyps (SSA/Ps), hyperplastic (HP) polyps and adenomas would be at highest risk of developing dysplasia/cancer compared to SSA/Ps alone, due to the synergistic effect of multiple active carcinogenic pathways. A prospective colonoscopy database was examined for patients with a history of SSA/P. Patients were placed into four groups based on patterns of polyp histology as follows: (i) only SSA/Ps; (ii) SSA/P + HP; (iii) SSA/Ps + adenomas; and (iv) SSA/Ps + HP + adenomas. These groups were compared in terms of the numbers, size, location and histology of polyps and personal or family history of colorectal cancer. A total of 374 patients were included. The average age was 70 years (range 21-88), and 43% were male. There was a trend towards the most aggressive neoplastic pattern in group 4, associated with a tendency to larger SSA/Ps, more villous architecture in the adenomas and more high-grade dysplasia in both types of polyps. It was also associated with multiplicity of both SSA/Ps and adenomas. No SSA/Ps existing in the absence of adenomas had cytological dysplasia. The combination of SSA/Ps, HP and adenomas in the colorectal epithelium seems to be a marker for aggressive carcinogenesis and suggests that accurate and effective surveillance is important to manage this risk.
Sections du résumé
BACKGROUND
Precursor colonic polyps of varied subtypes correlate with the known neoplastic pathways. When patients present with synchronous pre-malignant polyps of multiple histologies, multiple genetic mechanisms are likely to be active, potentially resulting in a more unstable, tumourigenic mucosa.
METHODS
We hypothesized that patients with a combination of sessile serrated adenomas/polyps (SSA/Ps), hyperplastic (HP) polyps and adenomas would be at highest risk of developing dysplasia/cancer compared to SSA/Ps alone, due to the synergistic effect of multiple active carcinogenic pathways. A prospective colonoscopy database was examined for patients with a history of SSA/P. Patients were placed into four groups based on patterns of polyp histology as follows: (i) only SSA/Ps; (ii) SSA/P + HP; (iii) SSA/Ps + adenomas; and (iv) SSA/Ps + HP + adenomas. These groups were compared in terms of the numbers, size, location and histology of polyps and personal or family history of colorectal cancer.
RESULTS
A total of 374 patients were included. The average age was 70 years (range 21-88), and 43% were male. There was a trend towards the most aggressive neoplastic pattern in group 4, associated with a tendency to larger SSA/Ps, more villous architecture in the adenomas and more high-grade dysplasia in both types of polyps. It was also associated with multiplicity of both SSA/Ps and adenomas. No SSA/Ps existing in the absence of adenomas had cytological dysplasia.
CONCLUSION
The combination of SSA/Ps, HP and adenomas in the colorectal epithelium seems to be a marker for aggressive carcinogenesis and suggests that accurate and effective surveillance is important to manage this risk.
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
807-811Informations de copyright
© 2020 Royal Australasian College of Surgeons.
Références
Vogelstein B, Kinzler KW. The path to cancer - three strikes and you're out. N. Engl. J. Med. 2015; 373: 1895-8.
Rex D, Ahnen D, Baron J et al. Serrated lesions of the colorectum: review and recommendations from an expert panel. Am. J. Gastroenterol. 2012; 107: 1315-29.
Mohammadi M, Garbyal RS, Kristensen MH, Madsen PM, Nielsen HJ, Holck S. Sessile serrated lesion and its borderline variant - variables with impact on recorded data. Pathol. Res. Pract. 2011; 207: 410-6.
Pai RK, Mackinnon AC, Joseph L, Noffsinger A, Hart J. Identification of histologically distinct conventional adenomas that arise predominately in patients with sessile serrated adenomas. Am. J. Surg. Pathol. 2010; 34: 355-63.
Jackman RJ, Mayo CW. The adenoma-carcinoma sequence in cancer of the colon. Surg. Gynecol. Obstet. 1951; 93: 327-30.
Morson B. Presidents address. The polyp-cancer sequence in the large bowel. Proc. R. Soc. Med. 1974; 67: 451-7.
Muto T, Bussey HJ, Morson BC. The evolution of cancer of the colon and rectum. Cancer 1975; 36: 2251-70.
He X, Wu K, Ogino S, Giovannucci EL, Chan AT, Song M. Association between risk factors for colorectal cancer and risk of serrated polyps and conventional adenomas. Gastroenterology 2018; 155: 355-73.
IJspeert J, Vermeulen L, Meijer G et al. Serrated neoplasia-role in colorectal carcinogenesis and clinical implications. Nat. Rev. Gastroenterol. Hepatol. 2015; 12: 401-9.
Kocarnik J, Shiovitz S, Phipps A. Molecular phenotypes of colorectal cancer and potential clinical applications. Gastroenterol. Rep. 2015; 3: 269-76.
Erichsen R, Baron J, Hamilton-Dutoit S et al. Increased risk of colorectal cancer development among patients with serrated polyps. Gastroenterology 2016; 150: 895-902.
Holme O, Bretthauer M, Eide T et al. Long term risk of colorectal cancer in individuals with serrated polyps. Gut 2015; 64: 929-36.
Lash R, Schuler C, Genta R. Demographic and pathological evaluation of 2139 patients with sessile serrated adenomas in one year period. Am. J. Gastroenterol. 2008; 103: S191.
Gurudu S, Heigh E, Heigh R et al. Sessile serrated adenomas; demographic, clinical and endoscopic characteristics in patient population. Am. J. Gastroenterol. 2008; 103: S177.
Vu HT, Lopez R, Bennett A, Burke CA. Individuals with sessile serrated polyps express an aggressive colorectal phenotype. Dis. Colon Rectum 2011; 54: 1216-23.
Costedio M, Church J. Pathways of carcinogenesis are reflected in patterns of polyp pathology in patients screened for colorectal cancer. Dis. Colon Rectum 2011; 54: 1224-8.
Worthley DL, Whitehall VL, Buttenshaw RL et al. DNA methylation within the normal colorectal mucosa is associated with pathway-specific predisposition to cancer. Oncogene 2010; 29: 1653-62.
Farchoukh L, Kuan SF, Dudley B, Brand R, Nikiforova M, Pai RK. MLH1-deficient colorectal carcinoma with wild-type BRAF and MLH1 promoter hypermethylation harbor KRAS mutations and arise from conventional adenomas. Am. J. Surg. Pathol. 2016; 40: 1390-9.
Spring KJ, Zhao ZZ, Karamatic R et al. High prevalence of sessile serrated adenomas with BRAF mutations: a prospective study of patients undergoing colonoscopy. Gastroenterology 2006; 131: 1400-7.
Juárez M, Egoavil C, Rodríguez-Soler M et al. KRAS and BRAF somatic mutations in colonic polyps and the risk of metachronous neoplasia. PLoS One 2017; 12: e0184937.
Kalady MF, Jarrar A, Leach B et al. Defining phenotypes and cancer risk in hyperplastic polyposis syndrome. Dis. Colon Rectum 2011; 54: 164-70.
Snover D, Ahnen DJ, Burt RW et al. Serrated polyps of the colon and rectum and serrated (‘hyperplastic’) polyposis. In: Bozman FT, Carneiro F, Hruban RH et al. (eds). WHO Classification of Tumours Pathology and Genetics Tumours of the Digestive System, 4th edn. Berlin: Springer-Verlag, 2010.
Jarrar AM, Church JM, Fay S, Kalady MF. Is the phenotype mixed or mistaken? Hereditary nonpolyposis colorectal cancer and hyperplastic polyposis syndrome. Dis. Colon Rectum 2009; 52: 1949-55.
Church J, Heald B, Burke C, Kalady M. Understanding MYH-associated neoplasia. Dis. Colon Rectum 2012; 55: 359-62.